ACE2
Basic information
Region (hg38): X:15494566-15607236
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- not_specified (15 variants)
- not_provided (7 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ACE2 gene is commonly pathogenic or not. These statistics are base on transcript: NM_001371415.1. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 19 | 2 | 1 | 22 | ||
| missense | 76 | 2 | 78 | |||
| nonsense | 14 | 14 | ||||
| start loss | 0 | |||||
| frameshift | 0 | |||||
| splice donor/acceptor (+/-2bp) | 21 | 21 | ||||
| Total | 0 | 0 | 130 | 4 | 1 |
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| ACE2 | protein_coding | protein_coding | ENST00000427411 | 18 | 41116 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 125627 | 2 | 6 | 125635 | 0.0000318 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 1.25 | 223 | 282 | 0.791 | 0.0000198 | 5358 |
| Missense in Polyphen | 72 | 101.38 | 0.71019 | 1960 | ||
| Synonymous | 1.33 | 84 | 101 | 0.832 | 0.00000736 | 1445 |
| Loss of Function | 4.66 | 3 | 31.0 | 0.0968 | 0.00000225 | 532 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.00 | 0.00 |
| Ashkenazi Jewish | 0.000163 | 0.0000992 |
| East Asian | 0.000160 | 0.000109 |
| Finnish | 0.00 | 0.00 |
| European (Non-Finnish) | 0.0000521 | 0.0000352 |
| Middle Eastern | 0.000160 | 0.000109 |
| South Asian | 0.0000654 | 0.0000327 |
| Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Carboxypeptidase which converts angiotensin I to angiotensin 1-9, a peptide of unknown function, and angiotensin II to angiotensin 1-7, a vasodilator. Also able to hydrolyze apelin- 13 and dynorphin-13 with high efficiency. May be an important regulator of heart function. {ECO:0000269|PubMed:10924499, ECO:0000269|PubMed:10969042, ECO:0000269|PubMed:14647384, ECO:0000269|PubMed:24227843}.; FUNCTION: (Microbial infection) Acts as a receptor for Human coronavirus NL63/HCoV-NL63. {ECO:0000269|PubMed:15897467}.;
- Pathway
- Agents Acting on the Renin-Angiotensin System Pathway, Pharmacodynamics;Renin-angiotensin system - Homo sapiens (human);Protein digestion and absorption - Homo sapiens (human);ACE Inhibitor Pathway, Pharmacodynamics;ACE Inhibitor Pathway;Peptide hormone metabolism;Metabolism of proteins;Metabolism of Angiotensinogen to Angiotensins
(Consensus)
Recessive Scores
- pRec
- 0.284
Intolerance Scores
- loftool
- 0.0718
- rvis_EVS
- 0.89
- rvis_percentile_EVS
- 89.14
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.0433
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Gene ontology
- Biological process
- regulation of cytokine production;angiotensin maturation;angiotensin-mediated drinking behavior;regulation of systemic arterial blood pressure by renin-angiotensin;tryptophan transport;regulation of vasoconstriction;receptor biosynthetic process;regulation of cell population proliferation;viral entry into host cell;receptor-mediated virion attachment to host cell;regulation of inflammatory response;positive regulation of amino acid transport;positive regulation of cardiac muscle contraction;regulation of blood vessel diameter;positive regulation of gap junction assembly;regulation of cardiac conduction;positive regulation of reactive oxygen species metabolic process
- Cellular component
- extracellular region;extracellular space;cytoplasm;plasma membrane;cell surface;integral component of membrane;brush border membrane;membrane raft;extracellular exosome
- Molecular function
- virus receptor activity;endopeptidase activity;carboxypeptidase activity;metallocarboxypeptidase activity;protein binding;metallopeptidase activity;exopeptidase activity;peptidyl-dipeptidase activity;zinc ion binding